⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13609 | 1.00 | — | — | |
| Benzene SCHEMBL27537719 | 0.91 | ALDH1A1 (0.40) | — | |
| Chloroform SCHEMBL27635521 | 0.88 | MEN1 (0.32) | — | |
| Aziridine SCHEMBL27342399 | 0.86 | PNMT (0.35) | — | |
| Diallylsulfone SCHEMBL9947 | 0.74 | — | — | |
| SCHEMBL2016950 | 0.74 | CA2 (0.32) | — | |
| Diallylsulfone SCHEMBL17707262 | 0.71 | CA2 (0.31) | — | |
| SCHEMBL982269 | 0.71 | — | — | |
| Diallylsulfone SCHEMBL9518459 | 0.71 | CA2 (0.31) | — | |
| SCHEMBL2813730 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2137173-A2 | PROCESS FOR THE PREPARATION OF PIPERAZINE BENZOTHIAZOLES | Laboratoires Serono SA (CH) | 2009-12-30 | — | — | EP | claimed |
| WO-2008125518-A2 | PROCESS FOR THE PREPARATION OF PIPERAZINE BENZOTHIAZOLES | MERCK SERONO S.A. (CH) | 2008-10-23 | — | — | WO | claimed |
| US-6034246-A | ANTICANCER AGENT | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 2000-03-07 | — | — | US | claimed |
| EP-0721336-B1 | BENZAZOLE COMPOUNDS FOR USE IN THERAPY | CANCER RES CAMPAIGN TECH (GB) | 1999-07-14 | — | — | EP | claimed |
| US-5874431-A | ANTITUMOR AGENTS; BREAST CANCER | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1999-02-23 | — | — | US | claimed |
| EP-0812319-A1 | 2-ARYLBENZAZOLE COMPOUNDS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1997-12-17 | — | — | EP | claimed |
| WO-1996026932-A1 | 2-ARYLBENZAZOLE COMPOUNDS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1996-09-06 | — | — | WO | claimed |
| US-10305063-B2 | Transparent organic electroluminescence element | Konica Minolta, Inc. (JP) | 2019-05-28 | — | — | US | disclosed |
| US-20190006614-A1 | TRANSPARENT ORGANIC ELECTROLUMINESCENCE ELEMENT | MERCK PATENT GMBH (DE) | 2019-01-03 | — | — | US | disclosed |
| WO-2014119698-A1 | PATTERN FORMING METHOD, COMPOUND USED THEREIN, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE, AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2014-08-07 | — | — | WO | disclosed |
| US-20100121057-A1 | Process for the Preparation of Piperazine Benzothiazoles | MERCK SERONO SA (CH) | 2010-05-13 | — | — | US | disclosed |
| EP-2137173-A2 | PROCESS FOR THE PREPARATION OF PIPERAZINE BENZOTHIAZOLES | Laboratoires Serono SA (CH) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008125518-A2 | PROCESS FOR THE PREPARATION OF PIPERAZINE BENZOTHIAZOLES | MERCK SERONO S.A. (CH) | 2008-10-23 | — | — | WO | disclosed |
| US-6034246-A | ANTICANCER AGENT | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 2000-03-07 | — | — | US | disclosed |
| EP-0721336-B1 | BENZAZOLE COMPOUNDS FOR USE IN THERAPY | CANCER RES CAMPAIGN TECH (GB) | 1999-07-14 | — | — | EP | disclosed |
| US-5874431-A | ANTITUMOR AGENTS; BREAST CANCER | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1999-02-23 | — | — | US | disclosed |
| EP-0812319-A1 | 2-ARYLBENZAZOLE COMPOUNDS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1997-12-17 | — | — | EP | disclosed |
| WO-1996026932-A1 | 2-ARYLBENZAZOLE COMPOUNDS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1996-09-06 | — | — | WO | disclosed |
| EP-0721336-A1 | BENZAZOLE COMPOUNDS FOR USE IN THERAPY | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1996-07-17 | — | — | EP | disclosed |
| WO-1995006469-A1 | BENZAZOLE COMPOUNDS FOR USE IN THERAPY | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1995-03-09 | — | — | WO | disclosed |